News
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the most notable here.
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...
Bristol-Myers Squibb’s trading volume rocketed to 6.93 billion on July 15, securing the 138th spot in market rankings. The company unveiled a strategic partnership with a biotech firm to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results